Category: Cardiac Implants
Medtronic touts a real-world study of its Reveal Linq insertable cardiac monitor for detecting atrial fibrillation and says a separate analysis shows that long-term implanted cardiac monitoring is cost-effective.
Neovasc reports positive data from a study of its stent-like device to treat refractory angina were published in the New England Journal of Medicine.
Neovasc (NYSE:NVC) said its device to treat refractory angina – implanted much like a coronary stent – met the endpoints in a clinical trial involving 104 patients.
SynCardia gains the FDA's O.K. to test its artificial heart as a permanent implant in 19 patients.
SynCardia plans to test its artificial heart as a permanent implant rather than a placeholder for donor transplants in 19 patients.
Sorin Group is beginning a U.S. rollout of a new surgical implant ring for addressing mitral valve repair issues.
Italy's Sorin Group (BIT:SRN) nailed down FDA clearance for a new surgical implant designed for use in mitral valve repair.
An FDA advisory panel's unprecedented 3rd hearing over Boston Scientific's Watchman anti-stroke device barely favors the cardiac implant.
An FDA advisory panel gives a mixed view in its unprecedented 3rd review of Boston Scientific's Watchman anti-stroke device.
The FDA expresses some doubts about new data from Boston Scientific on its Watchman anti-stroke device.